Search Results (245)

Growing interest in the future applications of nanotechnology in medicine has led to groundbreaking developments in nanosensors. Nanosensors are excellent platforms that provide reliable solutions for continuous monitoring and real-time detection of clinical targets. Nanosensors have attracted great attention due to their remarkable sensitivity, portability, selectivity, and automated data acquisition. The exceptional nanoscale properties of nanomaterials used in the nanosensors boost their sensing potential even at minimal concentrations of analytes present in a clinical sample. Along with applications in diverse sectors, the beneficial aspects of nanosensors have been exploited in healthcare systems to utilize their applications in diagnosing, treating, and preventing diseases. Hence, in this review, we have presented an overview of the disease-prognostic applications of nanosensors in chronic diseases through a detailed literature analysis. We focused on the advances in various nanosensors in the field of major diseases such as cancer, cardiovascular diseases, diabetes mellitus, and neurodegenerative diseases along with other prevalent diseases. This review demonstrates various categories of nanosensors with different nanoparticle compositions and detection methods suitable for specific diagnostic applications in clinical settings. The chemical properties of different nanoparticles provide unique characteristics to each nanosensors for their specific applications. This will aid the detection of potential biomarkers or pathological conditions that correlate with the early detection of various diseases. The potential challenges and possible recommendations of the applications of nanosensors for disease diagnosis are also discussed. The consolidated information present in the review will help to better understand the disease-prognostic potentials of nanosensors, which can be utilized to explore new avenues in improved therapeutic interventions and treatment modalities. Full article

Deep learning (DL) continues to play a pivotal role in a wide range of intelligent systems, including autonomous machines, smart surveillance, industrial automation, and portable healthcare technologies. These applications often demand low-latency inference and efficient resource utilization, especially when deployed on embedded or edge devices with limited computational capacity. As DL models become increasingly complex, selecting the right inference framework is essential to meeting performance and deployment goals. In this work, we conduct a comprehensive comparison of five widely adopted inference frameworks: PyTorch, ONNX Runtime, TensorRT, Apache TVM, and JAX. All experiments are performed on the NVIDIA Jetson AGX Orin platform, a high-performance computing solution tailored for edge artificial intelligence workloads. The evaluation considers several key performance metrics, including inference accuracy, inference time, throughput, memory usage, and power consumption. Each framework is tested using a wide range of convolutional and transformer models and analyzed in terms of deployment complexity, runtime efficiency, and hardware utilization. Our results show that certain frameworks offer superior inference speed and throughput, while others provide advantages in flexibility, portability, or ease of integration. We also observe meaningful differences in how each framework manages system memory and power under various load conditions. This study offers practical insights into the trade-offs associated with deploying DL inference on resource-constrained hardware. Full article

U-shaped architectures have achieved exceptional performance in medical image segmentation. Their aim is to extract features by two symmetrical paths: an encoder and a decoder. We propose a lightweight U-Net incorporating reverse attention and a preprocessing framework for accurate retinal vessel segmentation. This concept could be of benefit to portable or embedded recognition systems with limited resources for real-time operation. Compared to the baseline model (7.7 M parameters), the proposed U-Net model has only 1.9 M parameters and was tested on the DRIVE (Digital Retinal Images for Vesselness Extraction), CHASE (Child Heart and Health Study in England), and HRF (High-Resolution Fundus) datasets for vesselness analysis. The proposed model achieved Dice coefficients and IoU scores of 0.7871 and 0.6318 on the DRIVE dataset, 0.8036 and 0.6910 on the CHASE-DB1 Retinal Vessel Reference dataset, as well as 0.6902 and 0.5270 on the HRF dataset, respectively. Notably, the integration of the reverse attention mechanism contributed to a more accurate delineation of thin and peripheral vessels, which are often undetected by conventional models. The model comprised 1.94 million parameters and 12.21 GFLOPs. Furthermore, during inference, the model achieved a frame rate average of 208 FPS and a latency of 4.81 ms. These findings support the applicability of the proposed model in real-world clinical and mobile healthcare environments where efficiency and Accuracy are essential. Full article

Thoracic injuries account for a high percentage of combat casualty mortalities, with 80% of preventable deaths resulting from abdominal or thoracic hemorrhage. An effective method for detecting and triaging thoracic injuries is point-of-care ultrasound (POCUS), as it is a cheap and portable noninvasive imaging method. POCUS image interpretation of pneumothorax (PTX) or hemothorax (HTX) injuries requires a skilled radiologist, which will likely not be available in austere situations where injury detection and triage are most critical. With the recent growth in artificial intelligence (AI) for healthcare, the hypothesis for this study is that deep learning (DL) models for classifying images as showing HTX or PTX injury, or being negative for injury can be developed for lowering the skill threshold for POCUS diagnostics on the future battlefield. Three-class deep learning classification AI models were developed using a motion-mode ultrasound dataset captured in animal study experiments from more than 25 swine subjects. Cluster analysis was used to define the “population” based on brightness, contrast, and kurtosis properties. A MobileNetV3 DL model architecture was tuned across a variety of hyperparameters, with the results ultimately being evaluated using images captured in real-time. Different hyperparameter configurations were blind-tested, resulting in models trained on filtered data having a real-time accuracy from 89 to 96%, as opposed to 78–95% when trained without filtering and optimization. The best model achieved a blind accuracy of 85% when inferencing on data collected in real-time, surpassing previous YOLOv8 models by 17%. AI models can be developed that are suitable for high performance in real-time for thoracic injury determination and are suitable for potentially addressing challenges with responding to emergency casualty situations and reducing the skill threshold for using and interpreting POCUS. Full article

Antimicrobial resistance (AMR) is a rapidly growing global concern resulting from the overuse of antibiotics in both agricultural and clinical settings, the lack of surveillance for resistant bacteria, and the low quality of some available antimicrobial agents. Resistant pathogens are no longer susceptible to common clinical antimicrobials, which decreases the effectiveness of medicines used to treat infections caused by these organisms. Carbapenems are an important class of antibiotics due to their broad-spectrum effectiveness in treating infections caused by Gram-positive and Gram-negative organisms. Carbapenem-resistant bacteria have been found not only in healthcare but also in the environment and food supply chain, where they have the potential to spread to pathogens and infect humans and animals. Current methods of detecting AMR genes are expensive and time-consuming. While these methods, like polymerase chain reactions or whole-genome sequencing, are considered the “gold standard” for diagnostics, the development of inexpensive, rapid diagnostic assays is necessary for effective AMR detection and management. Biosensors have shown potential for success in diagnostic testing due to their ease of use, inexpensive materials, rapid results, and portable nature. Biosensors can be combined with nanomaterials to produce sensitive and easily interpretable results. This review presents an overview of carbapenem resistance, current and emerging detection methods of antimicrobial resistance, and the application of biosensors for rapid diagnostic testing for bacterial resistance. Full article

Musculoskeletal (MSK) disorders remain a major global cause of disability, with diagnostic complexity arising from their heterogeneous presentation and multifactorial pathophysiology. Recent advances across imaging modalities, molecular biomarkers, artificial intelligence applications, and point-of-care technologies are fundamentally reshaping musculoskeletal diagnostics. This review offers a novel synthesis by unifying recent innovations across multiple diagnostic imaging modalities, such as CT, MRI, and ultrasound, with emerging biochemical, genetic, and digital technologies. While existing reviews typically focus on advances within a single modality or for specific MSK conditions, this paper integrates a broad spectrum of developments to highlight how use of multimodal diagnostic strategies in combination can improve disease detection, stratification, and clinical decision-making in real-world settings. Technological developments in imaging, including photon-counting detector computed tomography, quantitative magnetic resonance imaging, and four-dimensional computed tomography, have enhanced the ability to visualize structural and dynamic musculoskeletal abnormalities with greater precision. Molecular imaging and biochemical markers such as CTX-II (C-terminal cross-linked telopeptides of type II collagen) and PINP (procollagen type I N-propeptide) provide early, objective indicators of tissue degeneration and bone turnover, while genetic and epigenetic profiling can elucidate individual patterns of susceptibility. Point-of-care ultrasound and portable diagnostic devices have expanded real-time imaging and functional assessment capabilities across diverse clinical settings. Artificial intelligence and machine learning algorithms now automate image interpretation, predict clinical outcomes, and enhance clinical decision support, complementing conventional clinical evaluations. Wearable sensors and mobile health technologies extend continuous monitoring beyond traditional healthcare environments, generating real-world data critical for dynamic disease management. However, standardization of diagnostic protocols, rigorous validation of novel methodologies, and thoughtful integration of multimodal data remain essential for translating technological advances into improved patient outcomes. Despite these advances, several key limitations constrain widespread clinical adoption. Imaging modalities lack standardized acquisition protocols and reference values, making cross-site comparison and clinical interpretation difficult. AI-driven diagnostic tools often suffer from limited external validation and transparency (“black-box” models), impacting clinicians’ trust and hindering regulatory approval. Molecular markers like CTX-II and PINP, though promising, show variability due to diurnal fluctuations and comorbid conditions, complicating their use in routine monitoring. Integration of multimodal data, especially across imaging, omics, and wearable devices, remains technically and logistically complex, requiring robust data infrastructure and informatics expertise not yet widely available in MSK clinical practice. Furthermore, reimbursement models have not caught up with many of these innovations, limiting access in resource-constrained healthcare settings. As these fields converge, musculoskeletal diagnostics methods are poised to evolve into a more precise, personalized, and patient-centered discipline, driving meaningful improvements in musculoskeletal health worldwide. Full article

This paper presents a novel, low-cost, portable impedance analyzer system designed for biopotential electrode evaluation and skin/electrode impedance measurement, critical for enhancing bioelectrical signal quality in healthcare applications. In contrast with conventional systems that depend on external PCs or host devices for data acquisition, visualization, and analysis, this design integrates all functionalities into a single, compact platform powered by the Analog Devices AD5933 impedance converter and a Raspberry Pi 4. The design incorporates custom analog circuitry to extend the measurement range from 10 Hz to 100 kHz and supports a wide impedance spectrum through switchable feedback resistors. Validated against a benchtop impedance analyzer, the system demonstrates high accuracy with normalized root-mean-square errors (NRMSEs) of 1.41% and 3.77% for the impedance magnitude and phase of passive components, respectively, and 1.43% and 1.29% for the biopotential electrode evaluation and skin/electrode impedance measurement. This cost-effective solution, with a total cost of USD 159, addresses the accessibility challenges faced by smaller research labs and healthcare facilities, offering a compact, low-power platform for reliable impedance analysis in biomedical applications. Full article

Integrating three-dimensional printing (3DP) in healthcare has modernized medical diagnostics and therapies by presenting various accurate, efficient, and patient-specific tailored solutions. This review critically examines the integration of 3DP in the development of miniaturized devices specifically tailored for point-of-care testing (PoCT) applications in healthcare. Focusing on progressive additive manufacturing techniques, such as material extrusion, vat photopolymerization, and powder bed fusion, the review classifies and evaluates their contributions toward designing compact, portable, and patient-specific diagnostic devices. Unlike previous reviews that treat 3DP or PoCT generically, this work uniquely bridges the technical innovations of 3DP with clinical applications by analyzing wearable sensors, biosensors, lab-on-chip systems, and microfluidic platforms. It highlights recent case studies, performance metrics, and the role of 3DP in enhancing diagnostic speed, accessibility, and personalization. The review also explores challenges such as material standardization and regulatory hurdles while outlining future directions involving artificial intelligence (AI), the Internet of Things (IoT), and multifunctional integration. This focused assessment establishes 3DP as a transformative force in decentralized and precision healthcare. Full article

Background: Falls among the elderly are a major public health concern, leading to increased disability and mortality. Traditional protective measures are important, but early detection and prevention are equally critical. Surface electromyography (sEMG) signals, which assess muscle electrical activity, can indicate a fall risk by detecting muscle weakness or instability. Objective: This narrative review synthesizes the research progress of sEMG in predicting neuromuscular falls among the elderly. Our goal is to explore the innovative application and development potential of the integration of sEMG and artificial intelligence (AI) in fall prevention among the elderly. Methods: A systematic search of PubMed, IEEE Xplore, and Web of Science (2013–2023) was conducted using the following keywords: artificial intelligence, wearable, sEMG, neuromuscular, and fall prediction. The inclusion criteria prioritized studies integrating sEMG with AI for elderly fall risk assessments, while non-empirical or non-English studies were excluded. Results: AI algorithms hold significant potential in medical applications, and studies on predicting neuromuscular falls in the elderly using sEMG signals have made notable progress. However, limitations include a reliance on simulated data, a lack of standardized models, sensor inaccuracies, and a focus on prediction rather than prevention. To address these challenges, this study proposes collecting authentic sEMG signals from elderly individuals with fall histories and healthy controls. By leveraging AI to develop predictive models and designing a portable sEMG acquisition and analysis system tailored for elderly communities, real-time fall risk predictions and early warnings can be achieved, thereby reducing fall incidences among the elderly. Conclusions: The combination of sEMG and AI presents a substantial promise for predicting neuromuscular falls in the elderly. Future research should prioritize validating models in real-world settings, refining sensor technology and signal processing techniques, and shifting focus toward comprehensive preventive strategies rather than mere prediction. These advancements could significantly enhance the quality of life and health outcomes of the elderly, while alleviating burdens on families and healthcare systems. Full article

Smart telemedicine represents an innovative application of information and communication technology within the healthcare sector, encompassing healthcare delivery, disease management, public health surveillance, education, and research. The commercialization of 5G and the extensive adoption of the Internet of Things (IoT) enable smart telemedicine devices to mitigate geographical and transmission delays, hence enhancing the quality of treatment provided to individuals. Although intelligent medicine is significant, previous studies emphasize the implementation and adoption of systems or technologies with few studies conducted on the platform of smart telemedicine equipment. This study aims to address the research gap by forecasting future developments and delineating smart telemedicine device designs utilizing platform-based design. We introduce a hybrid multi-criteria model that delineates the components of the intelligent medical platform. A portable 12-lead electrocardiogram (ECG) system is used by a global telemedicine technology company to assess the viability of the suggested framework. The portable 12-lead ECG device integrates artificial intelligence (AI), cloud computing, and 6G technology. The results of this study provide a basis for product creation by other smart telemedicine companies, while the platform-based analytical methodology can be employed for future product design. Full article

Background/Objectives: Gram staining is an essential diagnostic technique used for the rapid identification of bacterial and fungal infections, playing a pivotal role in clinical decision-making, especially in point-of-care (POC) settings. Manual staining, while effective, is labor-intensive and prone to variability, relying heavily on the skill of laboratory personnel. Current automated Gram-staining systems are primarily designed for high-throughput laboratory environments, limiting their feasibility in decentralized healthcare settings such as emergency departments and rural clinics. This study aims to introduce and evaluate the Point-of-Care Gram Stainer (PoCGS^®), a compact, automated device engineered for single-slide processing, addressing challenges related to portability, standardization, and efficiency in POC applications. Methods: The PoCGS^® device was developed to emulate expert manual staining techniques through features such as methanol fixation and programmable reagent application. A comparative evaluation was performed using 40 urine samples, which included both clinical and artificial specimens. These samples were processed using PoCGS^®, manual staining by skilled experts, and manual staining by unskilled personnel. The outcomes were assessed based on microbial identification concordance, the staining uniformity, presence of artifacts, and agreement with the culture results. Statistical analyses, including agreement rates and quality scoring, were conducted to compare the performance of PoCGS^® against manual staining methods. Results: PoCGS^® achieved a 100% concordance rate with expert manual staining in terms of microbial identification, confirming its diagnostic accuracy. However, staining quality parameters such as the uniformity and presence of artifacts showed statistically significant differences when compared to skilled and unskilled personnel. Despite these limitations, PoCGS^® demonstrated a comparable performance regarding artifact reduction and agreement with the culture results, indicating its potential utility in POC environments. Challenges such as fixed processing times and limited adaptability to varying specimen characteristics were identified as areas for further improvement. Conclusions: The study findings suggest that PoCGS^® is a reliable and valuable tool for microbial identification in POC settings, with a performance comparable to skilled manual staining. Its compact design, automation, and ease of use make it particularly beneficial for resource-limited environments. Although improvements in staining uniformity and background clarity are required, PoCGS^® has the potential to standardize Gram staining protocols and improve diagnostic turnaround times. Future developments will focus on optimizing staining parameters and expanding its application to other clinical sample types, ensuring robustness and broader usability in diverse healthcare settings. Full article

Hyperspectral imaging (HSI) is an advanced imaging technique that captures detailed spectral information across multiple fields. This review explores its applications in counterfeit detection, remote sensing, agriculture, medical imaging, cancer detection, environmental monitoring, mining, mineralogy, and food processing, specifically highlighting significant achievements from the past five years, providing a timely update across several fields. It also presents a cross-disciplinary classification framework to systematically categorize applications in medical, agriculture, environment, and industry. In counterfeit detection, HSI identified fake currency with high accuracy in the 400–500 nm range and achieved a 99.03% F1-score for counterfeit alcohol detection. Remote sensing applications include hyperspectral satellites, which improve forest classification accuracy by 50%, and soil organic matter, with the prediction reaching R² = 0.6. In agriculture, the HSI-TransUNet model achieved 86.05% accuracy for crop classification, and disease detection reached 98.09% accuracy. Medical imaging benefits from HSI’s non-invasive diagnostics, distinguishing skin cancer with 87% sensitivity and 88% specificity. In cancer detection, colorectal cancer identification reached 86% sensitivity and 95% specificity. Environmental applications include PM2.5 pollution detection with 85.93% accuracy and marine plastic waste detection with 70–80% accuracy. In food processing, egg freshness prediction achieved R² = 91%, and pine nut classification reached 100% accuracy. Despite its advantages, HSI faces challenges like high costs and complex data processing. Advances in artificial intelligence and miniaturization are expected to improve accessibility and real-time applications. Future advancements are anticipated to concentrate on the integration of deep learning models for automated feature extraction and decision-making in hyperspectral imaging analysis. The development of lightweight, portable HSI devices will enable more on-site applications in agriculture, healthcare, and environmental monitoring. Moreover, real-time processing methods will enhance efficiency for field deployment. These improvements seek to enhance the accessibility, practicality, and efficacy of HSI in both industrial and clinical environments. Full article

Optical Coherence Tomography (OCT) has revolutionized the diagnosis and management of retinal diseases, offering high-resolution, cross-sectional imaging that aids in early detection and continuous monitoring. However, traditional OCT devices are limited to clinical settings and require a technician to operate, which poses accessibility challenges such as a lack of appointment availability, patient and family burden of frequent transportation, and heightened healthcare costs, especially when treatable pathology is undetected. With the increasing global burden of retinal conditions such as age-related macular degeneration (AMD) and diabetic retinopathy, there is a critical need for improved accessibility in the detection of retinal diseases. Advances in biomedical engineering have led to innovations such as portable models, community-based systems, and artificial intelligence-enabled image analysis. The SightSync OCT is a community-based, technician-free device designed to enhance accessibility while ensuring secure data transfer and high-quality imaging (6 × 6 mm resolution, 80,000 A-scans/s). With its compact design and potential for remote interpretation, SightSync widens the possibility for community-based screening for vision-threatening retinal diseases. By integrating innovations in OCT imaging, the future of monitoring for retinal disease can be transformed to reduce barriers to care and improve patient outcomes. This article discusses the evolution of OCT technology, its role in the diagnosis and management of retinal diseases, and how novel engineering solutions like SightSync OCT are transforming accessibility in retinal imaging. Full article

The strong correlation between evoked potentials (EPs) and American Spinal Injury Association (ASIA) scores in individuals with spinal cord injury (SCI) suggests that EPs may serve as reliable predictive markers for rehabilitation progress. Numerous studies have confirmed a relationship between variations in somatosensory evoked potentials (SSEPs) and ASIA scores, especially in the early stages of SCI. Machine learning’s (ML’s) increasing importance in medicine is driven by the growing availability of health data and improved algorithms. It enables the creation of predictive models for disease diagnosis, progression prediction, personalized treatment, and improved healthcare efficiency. Data-driven approaches can significantly improve patient care, reduce costs, and facilitate personalized medicine. The meticulous analysis of medical data is crucial for timely disease identification, leading to effective symptom management and appropriate treatment. This study applies artificial intelligence to identify predictors of SCI progression, as measured by the disability index, ASIA impairment scale (AIS), and final motor recovery. We aim to clarify the prognostic role of electrophysiological testing (SSEPs, MEPs, and nerve conduction studies (NCSs)) in SCI. We analyzed data from a medical database of 123 records. We developed an ML-based intelligent system, utilizing ensemble algorithms combining decision trees and neural network approaches, to predict SCI recovery. Our evaluation showed SEP accuracies of 90% for motor recovery prediction and 80% for AIS scale determination, comparable to full electrophysiology evaluation accuracies of 93% and 89%, respectively, and generally superior results compared to MEP and NCS results. EPs emerged as the best predictors, comparable to a comprehensive electrophysiology assessment, significantly improving accuracy compared to clinical findings alone. An electrophysiological assessment, when available, increased overall accuracy for final motor recovery prediction to 93% (from a maximum of 75%) and, for ASIA score determination, to 89% (from a maximum of 66%). Further validation is needed with a larger dataset. Future research should validate that sensory electrophysiology assessment is a less expensive, portable, and simpler alternative to other prognostic tests and more effective than clinical assessments, like the AIS, biomarker for SCI, and personalized rehabilitation planning. Full article

The Monit4Healthy system is an IoT-enabled health monitoring solution designed to address critical challenges in real-time biomedical signal processing, energy efficiency, and data transmission. The system’s modular design merges wireless communication components alongside a number of physiological sensors, including galvanic skin response, electromyography, photoplethysmography, and EKG, to allow for the remote gathering and evaluation of health information. In order to decrease network load and enable the quick identification of abnormalities, edge computing is used for real-time signal filtering and feature extraction. Flexible data transmission based on context and available bandwidth is provided through a hybrid communication approach that includes Bluetooth Low Energy and Wi-Fi. Under typical monitoring scenarios, laboratory testing shows reliable wireless connectivity and ongoing battery-powered operation. The Monit4Healthy system is appropriate for scalable deployment in connected health ecosystems and portable health monitoring due to its responsive power management approaches and structured data transmission, which improve the resiliency of the system. The system ensures the reliability of signals whilst lowering latency and data volume in comparison to conventional cloud-only systems. Limitations include the requirement for energy profiling, distinctive hardware miniaturizing, and sustained real-world validation. By integrating context-aware processing, flexible design, and effective communication, the Monit4Healthy system complements existing IoT health solutions and promotes better integration in clinical and smart city healthcare environments. Full article